UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 442

Sortiert nach

Chronic E-Cigarette Use Increases Neutrophil Elastase and Matrix Metalloprotease Levels in the Lung

American journal of respiratory and critical care medicine, 2019-12, Vol.200 (11), p.1392-1401

2019

Link zum Volltext

Verfügbarkeit prüfen

Mucus accumulation in the lungs precedes structural changes and infection in children with cystic fibrosis

Science translational medicine, 2019-04, Vol.11 (486)

2019

Link zum Volltext

Verfügbarkeit prüfen

Drug exposure to infants born to mothers taking Elexacaftor, Tezacaftor, and Ivacaftor

Journal of cystic fibrosis, 2022-07, Vol.21 (4), p.725-727

2022

Link zum Volltext

Verfügbarkeit prüfen

Initial acquisition and succession of the cystic fibrosis lung microbiome is associated with disease progression in infants and preschool children

PLoS pathogens, 2018-01, Vol.14 (1), p.e1006798-e1006798

2018

Link zum Volltext

Verfügbarkeit prüfen

Chronic Mycobacterium abscessus infection and lung function decline in cystic fibrosis

Journal of cystic fibrosis, 2010-03, Vol.9 (2), p.117-123

2010

Link zum Volltext

Verfügbarkeit prüfen

Metabolomics of airways disease in cystic fibrosis

Current opinion in pharmacology, 2022-08, Vol.65, p.102238-102238, Article 102238

2022

Link zum Volltext

Verfügbarkeit prüfen

Inverse probability weighted estimation for recurrent events data with missing category

Statistics in medicine, 2021-05, Vol.40 (12), p.2765-2782

2021

Link zum Volltext

Verfügbarkeit prüfen

Potentiator ivacaftor abrogates pharmacological correction of ΔF508 CFTR in cystic fibrosis

Science translational medicine, 2014-07, Vol.6 (246), p.246ra96

2014

Link zum Volltext

Verfügbarkeit prüfen

Measured fetal and neonatal exposure to Lumacaftor and Ivacaftor during pregnancy and while breastfeeding

Journal of cystic fibrosis, 2018-11, Vol.17 (6), p.779-782

2018

Link zum Volltext

Verfügbarkeit prüfen

Regional Differences in Mucociliary Clearance in the Upper and Lower Airways

Frontiers in physiology, 2022-03, Vol.13, p.842592-842592

2022

Link zum Volltext

Verfügbarkeit prüfen

Metabolomic Evaluation of Neutrophilic Airway Inflammation in Cystic Fibrosis

Chest, 2015-08, Vol.148 (2), p.507-515

2015

Link zum Volltext

Verfügbarkeit prüfen

Lung transplant outcomes in cystic fibrosis patients with pre-operative Mycobacterium abscessus respiratory infections

Clinical transplantation, 2013-07, Vol.27 (4), p.523-529

2013

Link zum Volltext

Verfügbarkeit prüfen

Prolonged, physiologically relevant nicotine concentrations in the airways of smokers

American journal of physiology. Lung cellular and molecular physiology, 2023-01, Vol.324 (1), p.L32-L37

2023

Link zum Volltext

Verfügbarkeit prüfen

Congenital bilateral cataracts in newborns exposed to elexacaftor-tezacaftor-ivacaftor in utero and while breast feeding

Journal of cystic fibrosis, 2022-11, Vol.21 (6), p.1074-1076

2022

Link zum Volltext

Verfügbarkeit prüfen

An assessment of fellowship training issues affecting the pediatric pulmonary medicine workforce

Pediatric pulmonology, 2023-03, Vol.58 (3), p.665-669

2023

Link zum Volltext

Verfügbarkeit prüfen

An Improved Inhaled Mucolytic to Treat Airway Muco-obstructive Diseases

American journal of respiratory and critical care medicine, 2019-01, Vol.199 (2), p.171-180

2019

Link zum Volltext

Verfügbarkeit prüfen

Respiratory viruses are associated with common respiratory pathogens in cystic fibrosis

Pediatric pulmonology, 2014-09, Vol.49 (9), p.926-931

2014

Link zum Volltext

Verfügbarkeit prüfen

Effect of elexacaftor/tezacaftor/ivacaftor on mucus and mucociliary clearance in cystic fibrosis

Journal of cystic fibrosis, 2024-01, Vol.23 (1), p.155-160

2024

Link zum Volltext

Verfügbarkeit prüfen

Metabolomic biomarkers predictive of early structural lung disease in cystic fibrosis

The European respiratory journal, 2016-12, Vol.48 (6), p.1612-1621

2016

Link zum Volltext

Verfügbarkeit prüfen

Safety of sildenafil in premature infants with severe bronchopulmonary dysplasia (SILDI-SAFE): a multicenter, randomized, placebo-controlled, sequential dose-escalating, double-masked, safety study

BMC pediatrics, 2020-12, Vol.20 (1), p.559-9, Article 559

2020

Link zum Volltext

Verfügbarkeit prüfen

Gilbert's syndrome leads to elevated bilirubin after initiation of elexacaftor/tezacaftor/ivacaftor in people with cystic fibrosis

Pediatric pulmonology, 2024-04, Vol.59 (4), p.863-866

2024

Link zum Volltext

Verfügbarkeit prüfen

Airway Epithelial Inflammation In Vitro Augments the Rescue of Mutant CFTR by Current CFTR Modulator Therapies

Frontiers in pharmacology, 2021-03, Vol.12, p.628722-628722

2021

Link zum Volltext

Verfügbarkeit prüfen

Mass spectrometric analysis of biomarkers and dilution markers in exhaled breath condensate reveals elevated purines in asthma and cystic fibrosis

American journal of physiology. Lung cellular and molecular physiology, 2009-06, Vol.296 (6), p.L987-L993

2009

Link zum Volltext

Verfügbarkeit prüfen

Prospectively evaluating maternal and fetal outcomes in the era of CFTR modulators: the MAYFLOWERS observational clinical trial study design

BMJ open respiratory research, 2022-06, Vol.9 (1), p.e001289

2022

Link zum Volltext

Verfügbarkeit prüfen

Mapping targetable inflammation and outcomes with cystic fibrosis biomarkers

Pediatric pulmonology, 2017-11, Vol.52 (S48), p.S21-S28

2017

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 442

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(405)
Mit Volltextzugriff
(382)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(7)

Menü

Weitere Dienste

Einstellungen

Chronic E-Cigarette Use Increases Neutrophil Elastase and Matrix Metalloprotease Levels in the Lung

Mucus accumulation in the lungs precedes structural changes and infection in children with cystic fibrosis

Drug exposure to infants born to mothers taking Elexacaftor, Tezacaftor, and Ivacaftor

Initial acquisition and succession of the cystic fibrosis lung microbiome is associated with disease progression in infants and preschool children

Chronic Mycobacterium abscessus infection and lung function decline in cystic fibrosis

Metabolomics of airways disease in cystic fibrosis

Inverse probability weighted estimation for recurrent events data with missing category

Potentiator ivacaftor abrogates pharmacological correction of ΔF508 CFTR in cystic fibrosis

Measured fetal and neonatal exposure to Lumacaftor and Ivacaftor during pregnancy and while breastfeeding

Regional Differences in Mucociliary Clearance in the Upper and Lower Airways

Metabolomic Evaluation of Neutrophilic Airway Inflammation in Cystic Fibrosis

Lung transplant outcomes in cystic fibrosis patients with pre-operative Mycobacterium abscessus respiratory infections

Prolonged, physiologically relevant nicotine concentrations in the airways of smokers

Congenital bilateral cataracts in newborns exposed to elexacaftor-tezacaftor-ivacaftor in utero and while breast feeding

An assessment of fellowship training issues affecting the pediatric pulmonary medicine workforce

An Improved Inhaled Mucolytic to Treat Airway Muco-obstructive Diseases

Respiratory viruses are associated with common respiratory pathogens in cystic fibrosis

Effect of elexacaftor/tezacaftor/ivacaftor on mucus and mucociliary clearance in cystic fibrosis

Metabolomic biomarkers predictive of early structural lung disease in cystic fibrosis

Safety of sildenafil in premature infants with severe bronchopulmonary dysplasia (SILDI-SAFE): a multicenter, randomized, placebo-controlled, sequential dose-escalating, double-masked, safety study

Gilbert's syndrome leads to elevated bilirubin after initiation of elexacaftor/tezacaftor/ivacaftor in people with cystic fibrosis

Airway Epithelial Inflammation In Vitro Augments the Rescue of Mutant CFTR by Current CFTR Modulator Therapies

Mass spectrometric analysis of biomarkers and dilution markers in exhaled breath condensate reveals elevated purines in asthma and cystic fibrosis

Prospectively evaluating maternal and fetal outcomes in the era of CFTR modulators: the MAYFLOWERS observational clinical trial study design

Mapping targetable inflammation and outcomes with cystic fibrosis biomarkers

Suchergebnisse filtern